Ian F. Smith
CIK: 0001197032
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (23 total)
- Oct 2, 2026SLDB
Solid Biosciences Inc.
Exercise(M)Direct3.4K shares- - Jul 2, 2026SLDB
Solid Biosciences Inc.
Exercise(M)Direct3.4K shares- - Jun 24, 2026FHTX
Foghorn Therapeutics Inc.
Award(A)DirectStock Options (Right to buy)
28K shares at avg. $4.08- - Jun 10, 2026SLDB
Solid Biosciences Inc.
Award(A)DirectDirector Stock Option (Right to Buy)
77.5K shares- - May 7, 2026ODTX
Odyssey Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
27.4K shares- - Apr 2, 2026SLDB
Solid Biosciences Inc.
Exercise(M)Direct3.4K shares- - Feb 17, 2026STOK
Stoke Therapeutics, Inc.
Award(A)DirectRestricted Stock Units
129K shares- - Feb 17, 2026STOK
Stoke Therapeutics, Inc.
Award(A)DirectEmployee Stock Option (Right to Buy)
193K shares- - Jan 6, 2026SLDB
Solid Biosciences Inc.
Exercise(M)Direct4.6K shares- - Jan 2, 2026SLDB
Solid Biosciences Inc.
Award(A)DirectStock Option (Right to Buy)
18K shares- - Jan 2, 2026SLDB
Solid Biosciences Inc.
Award(A)DirectRestricted Stock Units
13.8K shares- - Oct 8, 2025STOK
Stoke Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
570K shares- - Oct 8, 2025STOK
Stoke Therapeutics, Inc.
Award(A)DirectRestricted Stock Units
380K shares- - Oct 6, 2025SLDB
Solid Biosciences Inc.
Exercise(M)Direct4.6K shares- - Jul 6, 2025SLDB
Solid Biosciences Inc.
Exercise(M)Direct4.6K shares- - Jun 17, 2025FHTX
Foghorn Therapeutics Inc.
Award(A)DirectStock Option (right to buy)
25K shares at avg. $4.79- - Jun 12, 2025SLDB
Solid Biosciences Inc.
Award(A)DirectDirector Stock Option (Right to Buy)
77.5K shares- - Apr 6, 2025SLDB
Solid Biosciences Inc.
Exercise(M)Direct4.6K shares- - Mar 20, 2025STOK
Stoke Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
238.4K shares- - Jan 6, 2025SLDB
Solid Biosciences Inc.
Award(A)DirectRestricted Stock Units
18.3K shares- - Jan 6, 2025SLDB
Solid Biosciences Inc.
Award(A)DirectStock Option (Right to Buy)
22.1K shares- - Jan 3, 2025SLDB
Solid Biosciences Inc.
Exercise(M)Direct3.3K shares- - Oct 3, 2024SLDB
Solid Biosciences Inc.
Exercise(M)Direct3.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 2, 2026 |  SLDB Solid Biosciences Inc. | Exercise(M) | 3,440 | - | $0 | Direct |
| Jul 2, 2026 | SLDB Solid Biosciences Inc. | Exercise(M) | 3,440 | - | $0 | Direct |
| Jun 24, 2026 |  FHTX Foghorn Therapeutics Inc. | Award(A) Stock Options (Right to buy) | 28,000 | $4.08 | - | Direct |
| Jun 10, 2026 | SLDB Solid Biosciences Inc. | Award(A) Director Stock Option (Right to Buy) | 77,500 | - | - | Direct |
| May 7, 2026 |  ODTX Odyssey Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 27,393 | - | - | Direct |
| Apr 2, 2026 | SLDB Solid Biosciences Inc. | Exercise(M) | 3,441 | - | $0 | Direct |
| Feb 17, 2026 |  STOK Stoke Therapeutics, Inc. | Award(A) Restricted Stock Units | 129,000 | - | - | Direct |
| Feb 17, 2026 | STOK Stoke Therapeutics, Inc. | Award(A) Employee Stock Option (Right to Buy) | 193,000 | - | - | Direct |
| Jan 6, 2026 | SLDB Solid Biosciences Inc. | Exercise(M) | 4,573 | - | $0 | Direct |
| Jan 2, 2026 | SLDB Solid Biosciences Inc. | Award(A) Stock Option (Right to Buy) | 18,012 | - | - | Direct |
| Jan 2, 2026 | SLDB Solid Biosciences Inc. | Award(A) Restricted Stock Units | 13,761 | - | - | Direct |
| Oct 8, 2025 | STOK Stoke Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 570,000 | - | - | Direct |
| Oct 8, 2025 | STOK Stoke Therapeutics, Inc. | Award(A) Restricted Stock Units | 380,000 | - | - | Direct |
| Oct 6, 2025 | SLDB Solid Biosciences Inc. | Exercise(M) | 4,573 | - | - | Direct |
| Jul 6, 2025 | SLDB Solid Biosciences Inc. | Exercise(M) | 4,573 | - | - | Direct |
| Jun 17, 2025 | FHTX Foghorn Therapeutics Inc. | Award(A) Stock Option (right to buy) | 25,000 | $4.79 | - | Direct |
| Jun 12, 2025 | SLDB Solid Biosciences Inc. | Award(A) Director Stock Option (Right to Buy) | 77,500 | - | - | Direct |
| Apr 6, 2025 | SLDB Solid Biosciences Inc. | Exercise(M) | 4,574 | - | - | Direct |
| Mar 20, 2025 | STOK Stoke Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 238,420 | - | - | Direct |
| Jan 6, 2025 | SLDB Solid Biosciences Inc. | Award(A) Restricted Stock Units | 18,293 | - | - | Direct |
| Jan 6, 2025 | SLDB Solid Biosciences Inc. | Award(A) Stock Option (Right to Buy) | 22,148 | - | - | Direct |
| Jan 3, 2025 | SLDB Solid Biosciences Inc. | Exercise(M) | 3,255 | - | $0 | Direct |
| Oct 3, 2024 | SLDB Solid Biosciences Inc. | Exercise(M) | 3,255 | - | $0 | Direct |
1-23 of 23 transactions
About SMITH IAN F
SMITH IAN F (SEC CIK 0001197032) files insider reports with the SEC as Director of Solid Biosciences Inc. (SLDB), Director of Foghorn Therapeutics Inc. (FHTX) and Director of Odyssey Therapeutics, Inc. (ODTX). Signal8 also holds filings tied to 1 other company.
Signal8 holds 18 ownership filings by SMITH IAN F (1 Form 3, 17 Form 4), filed between Oct 4, 2024 and Oct 6, 2026. Those filings report 23 transactions, from Oct 3, 2024 to Oct 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on SMITH IAN F's filings is in CHARLESTOWN, MA.
Recent filings by SMITH IAN F
- Oct 2, 2026: Option exercise of SLDB shares (Form 4, code M).
- Jul 2, 2026: Option exercise of SLDB shares (Form 4, code M).
- Jun 24, 2026: Grant or award of FHTX derivative securities (Form 4, code A).
- Jun 10, 2026: Grant or award of SLDB derivative securities (Form 4, code A).
- May 7, 2026: Grant or award of ODTX derivative securities (Form 4, code A).
Other insiders filing for Solid Biosciences Inc. (SLDB)
- Ganot Ilan, Director
- Brooks Gabriel, Chief Medical Officer
- RA CAPITAL MANAGEMENT, L.P., 10% Owner
- Nagendran Sukumar, Director
- PERCEPTIVE ADVISORS LLC, Director
- Keresty Georgia, Director